Perspectives

Prime’s missed refill program is a hit with Medicare plans

Two-touch rapid response program helped more members

August 19, 2018

Two-touch rapid response program helped more members to refill their prescriptions

Prime’s missed refill program was tested with nearly 83,000 Medicare members who had at least a seven-day gap in a CMS Star-adherence medication supply. First, members first got a phone call. Then, within one or two weeks, they got a reminder letter. The adherence rate for the members in the refill program rose 8%.

Read more

Can Lowering Generics Member Cost Share Impact CMS Star Adherence Metrics? (Spring 2018)

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit www.primetherapeutics.com and www.magellanrx.com, or follow us on Twitter at @Prime_PBM and @Magellan_Rx.

Related news

Perspectives

March 24, 2023

Look for Prime + Magellan Rx at AMCP 2023

Dr. Prerak Parikh (far left) and Dr. Sneha Sharma (far right) discuss trends…

Read More

Perspectives

March 23, 2023

Top female finance executive encourages DEI narrative

Over the past 30 years women’s careers in finance have seen significant progress,…

Read More

Perspectives

March 21, 2023

Top 10 acronyms in drug pipeline content, Part 2

News about biosimilars is everywhere. Sometimes you just need the basics. This four-part…

Read More
View all news